Systems Policy Analysis for Antimicrobial Resistance Targeted Action (SPAARTA): A Research Protocol.

Q1 Medicine
Wellcome Open Research Pub Date : 2025-07-30 eCollection Date: 2024-01-01 DOI:10.12688/wellcomeopenres.22923.2
Raheelah Ahmad, Nina Zhu, Rishabh Jain, Jyoti Joshi, Mirfin Mpundu, Paola Amigo Gutierrez, Alison Holmes, Tillman Weyde, Rifat Atun
{"title":"Systems Policy Analysis for Antimicrobial Resistance Targeted Action (SPAARTA): A Research Protocol.","authors":"Raheelah Ahmad, Nina Zhu, Rishabh Jain, Jyoti Joshi, Mirfin Mpundu, Paola Amigo Gutierrez, Alison Holmes, Tillman Weyde, Rifat Atun","doi":"10.12688/wellcomeopenres.22923.2","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The majority of countries (88%) have an Antimicrobial Resistance (AMR) National Action Plan (NAP V.1.0), but many remain unimplemented, and lack funding for interventions. Intervention selection requires a systematic approach to explain and predict progress. Looking beyond AMR is important to ensure the capture of systemic factors at the country level, which can impede or accelerate success.</p><p><strong>Aim: </strong>To provide innovative policy analysis to allow country comparison and refine targeted action, while developing and implementing NAPs (V.2.0).</p><p><strong>Methods: </strong>Mixed-method multi-country case study of policies and implementation strategies to address AMR across One Health. Starting with 17 countries, the sample includes each WHO region and emerging economies.This investigation of structures, processes, and outcomes has three components:a. Textual analysis of peer-reviewed literature, policy documents, global, national and state level progress reports, validated by global and in-country experts. An all-language article search conducted for 2000-2024, using broad search terms: 'Antimicrobial resistance policies', 'national action plan', 'surveillance', 'AMR systems' supplemented by hand searches. Deductive analysis using multi-disciplinary frameworks including the Expert Consensus for Implementation Research (ERIC). b. Longitudinal quantitative analysis assessing country contextual determinants and Antimicrobial Use (AMU) and AMR outcomes. Data from global health indicator repositories and international and national AMU and AMR surveillance networks are analysed using econometrics and machine learning approaches.c. Interactive Tableau dashboard development to display insights from a & b to allow visualisation and comparison of case-country AMR intervention context and components.</p><p><strong>Discussion: </strong>This protocol provides a systematic, transparent approach for countries to benchmark their own AMR strategies. The interactive dashboard will allow comparisons between country clusters by geography or economy, and enable rapid knowledge mobilisation among strategic and operational stakeholders including policy makers and planners. This protocol facilitates others to perform this structured assessment and nominate their country for the next wave of analysis.</p>","PeriodicalId":23677,"journal":{"name":"Wellcome Open Research","volume":"9 ","pages":"700"},"PeriodicalIF":0.0000,"publicationDate":"2025-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12332476/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Wellcome Open Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12688/wellcomeopenres.22923.2","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The majority of countries (88%) have an Antimicrobial Resistance (AMR) National Action Plan (NAP V.1.0), but many remain unimplemented, and lack funding for interventions. Intervention selection requires a systematic approach to explain and predict progress. Looking beyond AMR is important to ensure the capture of systemic factors at the country level, which can impede or accelerate success.

Aim: To provide innovative policy analysis to allow country comparison and refine targeted action, while developing and implementing NAPs (V.2.0).

Methods: Mixed-method multi-country case study of policies and implementation strategies to address AMR across One Health. Starting with 17 countries, the sample includes each WHO region and emerging economies.This investigation of structures, processes, and outcomes has three components:a. Textual analysis of peer-reviewed literature, policy documents, global, national and state level progress reports, validated by global and in-country experts. An all-language article search conducted for 2000-2024, using broad search terms: 'Antimicrobial resistance policies', 'national action plan', 'surveillance', 'AMR systems' supplemented by hand searches. Deductive analysis using multi-disciplinary frameworks including the Expert Consensus for Implementation Research (ERIC). b. Longitudinal quantitative analysis assessing country contextual determinants and Antimicrobial Use (AMU) and AMR outcomes. Data from global health indicator repositories and international and national AMU and AMR surveillance networks are analysed using econometrics and machine learning approaches.c. Interactive Tableau dashboard development to display insights from a & b to allow visualisation and comparison of case-country AMR intervention context and components.

Discussion: This protocol provides a systematic, transparent approach for countries to benchmark their own AMR strategies. The interactive dashboard will allow comparisons between country clusters by geography or economy, and enable rapid knowledge mobilisation among strategic and operational stakeholders including policy makers and planners. This protocol facilitates others to perform this structured assessment and nominate their country for the next wave of analysis.

Abstract Image

抗微生物药物耐药性靶向行动的系统政策分析(SPAARTA):一项研究方案。
背景:大多数国家(88%)制定了抗微生物药物耐药性(AMR)国家行动计划(NAP V.1.0),但许多国家仍未实施,并且缺乏干预措施的资金。干预措施的选择需要一个系统的方法来解释和预测进展。要确保在国家一级捕捉可能阻碍或加速成功的系统性因素,重要的是要超越抗微生物药物耐药性。目的:在制定和实施国家行动计划(V.2.0)的同时,提供创新的政策分析,以便进行国家比较并完善有针对性的行动。方法:混合方法的多国案例研究的政策和实施战略,以解决单一健康。样本从17个国家开始,包括世卫组织各区域和新兴经济体。这种对结构、过程和结果的调查有三个组成部分:经全球和国内专家验证的同行评议文献、政策文件、全球、国家和州一级进展报告的文本分析。对2000-2024年的全语言文章进行检索,使用广泛的检索词:“抗菌素耐药性政策”、“国家行动计划”、“监测”、“抗菌素耐药性系统”,并辅以手动检索。运用包括实施研究专家共识(ERIC)在内的多学科框架进行演绎分析。b.纵向定量分析,评估国家环境决定因素和抗菌素使用(AMU)和AMR结果。使用计量经济学和机器学习方法分析来自全球健康指标库以及国际和国家抗菌素和抗菌素耐药性监测网络的数据。交互式Tableau仪表板开发,显示来自a和b的见解,以实现病例-国家抗菌素耐药性干预上下文和组件的可视化和比较。讨论:该议定书为各国提供了一个系统的、透明的方法来对其自身的抗微生物药物耐药性战略进行基准测试。交互式仪表板将允许按地理或经济对国家集群进行比较,并使包括决策者和规划者在内的战略和业务利益攸关方能够快速调动知识。该议定书有助于其他国家进行这种结构化评估,并提名其国家进行下一波分析。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Wellcome Open Research
Wellcome Open Research Biochemistry, Genetics and Molecular Biology-Biochemistry, Genetics and Molecular Biology (all)
CiteScore
5.50
自引率
0.00%
发文量
426
审稿时长
1 weeks
期刊介绍: Wellcome Open Research publishes scholarly articles reporting any basic scientific, translational and clinical research that has been funded (or co-funded) by Wellcome. Each publication must have at least one author who has been, or still is, a recipient of a Wellcome grant. Articles must be original (not duplications). All research, including clinical trials, systematic reviews, software tools, method articles, and many others, is welcome and will be published irrespective of the perceived level of interest or novelty; confirmatory and negative results, as well as null studies are all suitable. See the full list of article types here. All articles are published using a fully transparent, author-driven model: the authors are solely responsible for the content of their article. Invited peer review takes place openly after publication, and the authors play a crucial role in ensuring that the article is peer-reviewed by independent experts in a timely manner. Articles that pass peer review will be indexed in PubMed and elsewhere. Wellcome Open Research is an Open Research platform: all articles are published open access; the publishing and peer-review processes are fully transparent; and authors are asked to include detailed descriptions of methods and to provide full and easy access to source data underlying the results to improve reproducibility.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信